National Cancer Registry

Definition	A cancer registry is defined as a location, be it an office or institution, where collection, storage, analysis and interpretation of data on cancer patients take place (Jenson et al, 1991).
Objectives	- To measure cancer incidence - To describe cancer by time, place, persons and disease - To provide a national database for further epidemiological research
Case definition	Target cases are: - Incident cases by year of diagnosis - Malignant tumors confirmed by histopathology and/or hematology findings - Cancers of all sites
Sources of data	Data are collected through two main channels: the capture system (passive reporting) and the recapture system (active reporting). 1) The capture system: The capture system is based on physician’s routine reporting of cancer cases. Physician’s complete and send forms: - Directly from their clinic; or - Indirectly through the MOPH Drug Dispensing Center (DDC), where anti-cancer drugs are distributed to eligible patients 2) The recapture system: The recapture system is based on gathering information directly from histopathological and hematological laboratories. Data are collected in various ways, using hard or soft copies, or using database file or individual laboratory results depending on laboratories resources. This process is active since the NCR personnel actually contact the sites to obtain the necessary data. The recapture system validates and complements the capture approach.
Medical coding	The coding of cancer primary sites and cancer morphology is done using International Classification of Diseases for Oncology, third edition (ICD-O-3). The code includes information on the topography (primary site), the histology, the behavior and the grade of the tumor. The structure is C##.# M####/##, where: - C##.# specifies the primary site - M#### specifies the histology - /## specifies the behavior and the grade of the tumor
Reporting form	NCR reporting form

ATC	Name	B/G	Ingredients	Dosage	Form	Price
A02BC01	STOMAZOLE	G	Omeprazole - 20mg	20mg	Capsule	593,850 L.L
L01EX01	SUNITINIB AQVIDA	G	Sunitinib maleate - 50mg	50mg	Capsule, hard	125,308,072 L.L
A02BC01	STOMAZOLE	G	Omeprazole - 20mg	20mg	Capsule	15,757,784 L.L
A07EC02	SALCROZINE	G	Mesalazine - 1g	1g	Tablet, gastroresistant	4,073,187 L.L
N02BE01	SULDEX A	G	Paracetamol - 600mg	600mg	Suppository	200,936 L.L
L04AA27	SCLEMOD	G	Fingolimod Hydrochloride - 0.5mg	0.5mg	Capsule	L.L
A07EC02	SALCROZINE	G	Mesalazine - 500mg	500mg	Suppository	576,508 L.L
N02BE01	SULDEX 125	G	Paracetamol - 125mg	125mg	Suppository	110,067 L.L
A07EC02	SALCROZINE	G	Mesalazine - 1000mg	1000mg	Suppository	2,306,034 L.L
B05CX01	SERUFLEX DEXTROSE 5% INJECTION USP	G	Glucose - 5%	5%	Injectable solution	171,228 L.L
B05CX01	SERUFLEX DEXTROSE 5% INJECTION USP	G	Glucose - 5%	5%	Injectable solution	158,587 L.L
B05CX01	SERUFLEX DEXTROSE 5% INJECTION, USP	G	Glucose - 5%	5%	Injectable solution	171,228 L.L
B05CX01	SERUFLEX DEXTROSE 5% INJECTION, USP	G	Glucose - 5%	5%	Injectable solution	193,062 L.L
C05AA01	SEDIPROCT	G	Hydrocortisone - 500mg, Cinchocaine HCl - 500mg		Cream	290,270 L.L
B05CX01	SOLUFLEX DEXTROSE 5% INJECTION USP	G	Glucose - 5%	5%	Injectable solution	186,167 L.L
C05AA01	SEDIPROCT	G	Hydrocortisone - 5mg, Cinchocaine HCl - 5mg, Framycetin sulfate - 10mg, Esculoside - 10mg		Suppository	237,860 L.L
B05CX01	SOLUFLEX DEXTROSE 5% INJECTION USP	G	Glucose - 5%	5%	Injectable solution	186,167 L.L
C05AA01	SINAHEAL-H	G	Hydrocortisone acetate - 5mg, Lidocaine - 60mg, Zinc oxide - 400mg, Aluminium Subacetate - 50mg		Suppository	501,253 L.L
B05CX01	SOLUFLEX DEXTROSE 5% INJECTION, USP	G	Glucose - 5%	5%	Injectable solution	205,703 L.L
C05AA01	SINAHEAL-H	G	Hydrocortisone acetate - 0.275g/100g, Lidocaine - 5g/100g, Zinc oxide - 18g/100g, Aluminium Subacetate - 3.5g/100g		Ointment	330,585 L.L
B05CX01	SOLUFLEX DEXTROSE 5% INJECTION, USP	G	Glucose - 5%	5%	Injectable solution	221,792 L.L
B05CX01	SOLUFLEX DEXTROSE 5% INJECTION, USP	G	Glucose - 5%	5%	Injectable solution	268,908 L.L
C10AA07	SINLIP	G	Rosuvastatin (calcium) - 10mg	10mg	Tablet, film coated	563,070 L.L
C10AA07	SUPERSTAT	G	Rosuvastatin (calcium) - 10mg	10mg	Tablet, coated	517,379 L.L
J01DD01	STOPAREN	G	Cefotaxime (sodium) - 1g	1g	Injectable lyophilised powder for solution+diluent	213,671 L.L
N02BE01	STOPALGIC	G	Paracetamol - 1g/100ml	1g/100ml	Injectable solution	1,536,012 L.L
D10AF02	SPOTEX	G	Erythromycin - 4%	4%	Gel	854,684 L.L
J01RA	SPIRAGYL	G	Metronidazole - 125mg, Spiramycin - 750,000IU		Tablet, scored	474,824 L.L
J01RA	SPIRAGYL FORTE	G	Metronidazole - 250mg, Spiramycin - 1,500,000IU		Tablet, scored	474,824 L.L
G04CA04	SILODOSINE ARROW	G	Silodosine - 4mg	4mg	Capsule	732,394 L.L

National Cancer Registry (NCR)